CLINICAL ASSESSMENT OF SAFETY, PHARMACOKINETICS, AND EFFICACY OF IMMUNE GLOBULIN INTRAVENOUS 10% IN PEDIATRIC PATIENTS

被引：0
|
作者：
Melamed, I.
Walter, J.
Alpan, O.
Jhaveri, D.
Koterba, A.
Leiding, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P167
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] A new intravenous immune globulin, 10% liquid, triple virus reduced (IGIV, 10% TVR) - Pharmacokinetics, efficacy and safety in patients with primary immunodeficiency
    Leibl, Heinz
    Church, Joseph A.
    Stein, Mark R.
    Melamed, Isaac R.
    Rubinstein, Ayre
    Schneider, Lynda C.
    Wasserman, Richard L.
    Pavlova, Borislava G.
    Birthistle, Karl
    Mancini, Marianne
    Fritsch, Sandor
    Moore-Perry, Kerry
    Ehrlich, Hartmut J.
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 500 - 500
  • [2] Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency
    Joseph A. Church
    Heinz Leibl
    Mark R. Stein
    Isaac R. Melamed
    Arye Rubinstein
    Lynda C. Schneider
    Richard L. Wasserman
    Borislava G. Pavlova
    Karl Birthistle
    Marianne Mancini
    Sandor Fritsch
    Lisa Patrone
    Kerry Moore-Perry
    Hartmut J. Ehrlich
    Journal of Clinical Immunology, 2006, 26 : 388 - 395
  • [3] Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency
    Church, Joseph A.
    Leibl, Heinz
    Stein, Mark R.
    Melamed, Isaac R.
    Rubinstein, Arye
    Schneider, Lynda C.
    Wasserman, Richard L.
    Pavlova, Borislava G.
    Birthistle, Karl
    Mancini, Marianne
    Fritsch, Sandor
    Patrone, Lisa
    Moore-Perry, Kerry
    Ehrlich, Hartmut J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (04) : 388 - 395
  • [4] SAFETY AND PHARMACOKINETICS OF A SOLVENT DETERGENT-TREATED INTRAVENOUS IMMUNE GLOBULIN
    POLMAR, S
    CALLAN, R
    GEHA, R
    COX, D
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 144 - 144
  • [5] Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
    Kai Uwe Radomski
    Georg Lattner
    Torben Schmidt
    Jürgen Römisch
    BioDrugs, 2017, 31 : 125 - 134
  • [6] Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
    Radomski, Kai Uwe
    Lattner, Georg
    Schmidt, Torben
    Roemisch, Juergen
    BIODRUGS, 2017, 31 (02) : 125 - 134
  • [7] Efficacy, Safety, and Tolerability of Prometics Immune Globulin Intravenous (Human) 10% (Prometic 10% IGIV) in Adult and Pediatric Subjects with Primary Immunodeficiency Diseases (PIDD)
    Kanekar, Shalini
    Moy, James
    Trybul, Diane
    Parker, Joseph
    Albert, Gary
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 358 - 358
  • [8] Safety, Efficacy, and Pharmacokinetics of Flebogamma® 5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases
    Melvin Berger
    Paul J. Pinciaro
    Journal of Clinical Immunology, 2004, 24 : 389 - 396
  • [9] Safety, efficacy, and pharmacokinetics of Flebogamma® 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases
    Berger, M
    Pinciaro, PJ
    JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (04) : 389 - 396
  • [10] EFFICACY AND PHARMACOKINETICS OF INTRAVENOUS IMMUNE GLOBULIN ADMINISTRATION TO HIGH-RISK NEONATES
    KINNEY, J
    MUNDORF, L
    GLEASON, C
    LEE, C
    TOWNSEND, T
    THIBAULT, R
    NUSSBAUM, A
    ABBY, H
    YOLKEN, R
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1991, 145 (11): : 1233 - 1238
12345